Surrey Heartlands

Joint Formulary & PAD

Fusidic acid - Bacterial infection

You are here : Home > Formulary Search > Fusidic acid - Bacterial infection

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Suspension
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important
Follow local guidelines on the use of antimicrobials. Use in primary care when indicated by microbiology eg on culture results. Note - licensed products are being discontinued in 2025.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Fusidic acid
Indication :
Bacterial infection
Group Name :
Keywords :
antibiotic, antibacterial
Brand Names Include :
Fucidin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Fusidic acid is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Bacterial infection.

Committee Recommendations (2)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Fusidic acid (Fucidin) 250mg tablets and 250mg/5ml oral suspension are being discontinued in Jan 2025 and Jun 2025 respectively.
The Specialist Pharmacy Service (SPS) have issued advice on appropriate actions and alternative, unlicensed preparations: https://www.sps.nhs.uk/shortages/discontinuation-of-sodium-fusidate-fucidin-250mg-tablets-and-fusidic-acid-fucidin-250mg-5ml-oral-suspension/

01 May 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.